J.O.S.A.N.A...M.E.D.I.:.C.A.L...M.R.I.•.S.C.A.N...S.T.U.D.I.O.S
.J..O..S..A..N..A .M E D I : C A L.
M.R.I.+.M.R.A.,B.,C•S.C.A.N.+.SCREENING.PRO:JECT
3D–M.R.I+M.RA,B,C.•.SLICE-IMAGES:DIAGNOSTIC
------------------------------------------------------------------------
.JOSANA..MEDI:CAL M R I..•
S C A N..PRO:JECT.
.A v e r t i n g..(.A.v.o.i.d.a.n.c.e.)..
an ".E &.H –.C U T T I N G.".
.with worldwide Exclusion.
------------------------------------------------------------------------
.(
E n g l i s h
version*).
*K.I.–supported translation.
*K.I.–supported translation.
------------------------------------------------------------------------
.P a g e : R.1.a.
.P a g e : R.1.a.
(
Sequel
/
Continuation
)
of a total of.14 pages
JOSANA MEDI:CAL M R I •
S C A N PRO:JECT
Worldwide..M R.I.•
S.T.U.D.I.O –.C.h.a.i.n
----------------------------------------------------------------------------------------
JOSANA MEDI:CAL M R I •
S C A N..PRO:JECT.
----------------------------------------------------------------------------------------
P a y m e n t..– C o n d i t i o n s..#.I.I.
for the "Access–Fees".
(=.Support–Contribution.).
for the limited.,.t h r e e [3] days Access into the.
INTERNET–Information–DOSSIER
#.I.I.I.
>.Confidential Information Memorandum.<.
----------------------------------------------------------------------------------------
Payment–Terms+Condition
#III
>1<
In the contrast to the preceding INTERNET–Information–DOSSIER #.I.I
>F I R S T – I N F O R M A T I O N<.,
which is available during a limited pe-riod of eighteen [18]
working days (.including Saturdays +.Sundays +.Public Holidays.)
for the ".I n s p e c t i o n –.R.i.g.h.t.".(".R e a d +.R e v i e w +.E x -
a m i n a t i o n – P r i v i l e g e.")
against payment of a >Deputy:Office– o r
(.alternatively.)
Main:/Headquarters–Contact-Protection:Fee< by o n e [1]
or by several [1+] "Contact+Deputy–Office/s" (= Branch/"Field–Office")
o r..by the a c t i v e l y examining "Main:/Headquarters:Office"
of a (.poten-tially.)
interested and suitable FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITU-
TION.,
ORGANISATION or GROUP ["Interested Party"].,
supplemented by
the payment of a
>Company*:.Group–Contact-Protection.:.Fee< (*.stands
for
:
FIRMS.,
COMPANIES.,
ENTERPRISES.,
INSTITUTIONS.,
ORGANISATIONS
and/or GROUPS ).,
the amount of which is calculated individually according
to the "
V a l u a t i o n – C l a s s e s "
of the JOSANA MEDI:CAL – "H &.E".– Company–Valuation–Classification A.T.O.S.,
and which can be viewed and
checked on the Internet regardless of the location.,
will be made available
and accessible the in–depth and s t r i c t l y..c o n f i d e n t i a l..details and
background of the revolutionary and highly lucrative worldwide JOSANA
MEDI:CAL M R I • S C A N PRO:JECT c o m p r e h e n s i v e l y and including
the d e t a i l e d INTERNET–Information–DOSSIER #.I.I.I
>Confidential In-formation Memorandum< [".C.I.M."]
with the BUSINESS–PLAN..in all the
d e t a i l s..for an onto t h r e e [3]
working days limited ".I n s p e c t i o n –
R i g h t." (".R e a d + R e v i e w + E x a m i n a t i o n – P r i v i l e g e.")
ex-clusively by formally approved "Authorised"
Readers and Examiners ["Test–
Adlates"]
of "Interested Parties"
in a C.O.O.P.E.R.A.T.I.O.N..and P.A.R.T.I.C.I.-
P A T I O N
within the framework of the JOSANA MEDI:CAL M R I • S C A N
PRO:JECT against an
>Access+License:Fee< to be paid by the "Interested
Party"
as well as against a >Read+Checking:Fee< payable for e a c h.(=.per) "Test–Adlatus"
["Authorised"
Readers and Examiners.]
o n l y and e x c l u -
s i v e l y in the rooms (.on the premises.)
of the N O T.A R.Y.'.S –.O F F I C E S expressly approved in advance by the JOSANA MEDI:CAL PRO:JECT – Con-ceptors and JOSANA MEDI:CAL LONG:TERM DISEASE.:.PREVENTION M R I +
MRA/MRB/MRC • S C R E E N I N G ["S C A N"]
PRO:JECT – Initiators +.Ar-chitects +.Licensors • Z I M M E R M A N N..& R E H N I
S C H •
Payment–Terms+Condition #III
>2<
.
The >Read+Checking:Fee< for e a c h (=.per.) "Test–Adlatus"
["Authorised"
Readers and Examiners.]
as well as the
>Access+Li-cense:Fee< of an inter-ested and potentially suitable FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITU-TION.,
ORGANISATION or GROUP for a function and a status as '.B.U.I.L.D.-I.N.G–U.P.–.C O O P E R A N T.'
and '.B.U.I.L.D.I.N.G–U.P.–.P A R T I C I P A N T.'
of the worldwide JOSANA MEDI:CAL M R I • S C A N PRO:JECT ["Interested
Party"]
will be calculated -- like all other fees.,
contributions and charges in
favour of the "JOSANA MEDICAL MRI STUDIOS LICENSING LIMITED"
-- in
accordance with the previous classification in the total f i v e [5] ".V a l u a -
t i o n – C l a s s e s."
of the JOSANA MEDI:CAL – "H &.E".– Company–Valua-tion–Classification
A.T.O.S.
Payment–Terms+Condition #III
>3<
The ".H.&.E.".– Company–Valuation–Classification A.T.O.S.
is based on the
".C o n t a c t – L i s t.".(.E X C E L.®
– list.)
created by the JOSANA MEDI:CAL
PRO:JECT – Conceptors with the FIRMS.,
COMPANIES.,
ENTERPRISES.,
INSTI-TUTIONS.,
ORGANISATIONS and GROUPS that are (.potentially.)
interested
and suitable for a function and status as '.B U I L D I N G–U P – C O O P E R -
A N T S.'
and '.B U I L D I N G–U P – P A R T I C I P A N T S.'
of the worldwide
JOSANA MEDI:CAL M R I • S C A N PRO:JECT.,
which.,
depending on their
respective importance for the JOSANA MEDI:CAL M R I • S C A N PRO:JECT.,
are divided into a total of five [5].".V a l u a t i o n – C l a
s s e s.".
For the ".V a l u a t i o n –.C l a s s e s." of the JOSANA MEDI:CAL –."H.&.E".– Company–Valuation–Classification A.T.O.S. the following criteria are taken
Payment–Terms+Condition #III
>4<
For the ".V a l u a t i o n –.C l a s s e s." of the JOSANA MEDI:CAL –."H.&.E".– Company–Valuation–Classification A.T.O.S. the following criteria are taken
into account :
1.. the worldwide number of e m p l o y e e s (.both self–employed and
1.. the worldwide number of e m p l o y e e s (.both self–employed and
employed.)
of the respective FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP
2.. the number of c o u n t r i e s in which the respective FIRM., COMPANY.,
2.. the number of c o u n t r i e s in which the respective FIRM., COMPANY.,
ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP has subsidiaries.,
branches or "external./.field–offices",
regardless of their type
3.. the worldwide number of subsidiaries., b r a n c h e s and "external./
3.. the worldwide number of subsidiaries., b r a n c h e s and "external./
field–offices"
of the respective FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITU-TION.,
ORGANISATION or GROUP
4.. the..i m p o r t a n c e of the respective FIRM., COMPANY., ENTERPRISE.,
4.. the..i m p o r t a n c e of the respective FIRM., COMPANY., ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP for the worldwide HEALTH sector
,
MEDICAL technology and the worldwide MEDICAL industry
5.. the e x p e c t e d importance of the respective FIRM., COMPANY., EN-TERPRISE., INSTITUTION., ORGANISATION or GROUP for the worldwide
5.. the e x p e c t e d importance of the respective FIRM., COMPANY., EN-TERPRISE., INSTITUTION., ORGANISATION or GROUP for the worldwide
JOSANA MEDI:CAL LONG:TERM DISEASE:PREVENTION M R I + MRA/MRB/MRC • S C R E E N I N G ["S C A N"] PRO:JECT -- called JOSANA MEDI:CAL
M R I • S C A N PRO:JECT
6.. the current and future..e c o n o m i c – s t r e n g t h of the respective
6.. the current and future..e c o n o m i c – s t r e n g t h of the respective
FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP
7.. the current and expected..i n n o v a t i o n – p o w e r ("Eruptive–
7.. the current and expected..i n n o v a t i o n – p o w e r ("Eruptive–
Power")
of the respective FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP
8.. the ".B i e n s t o c k." ("Beehive") – effect of the respective FIRM.,
8.. the ".B i e n s t o c k." ("Beehive") – effect of the respective FIRM.,
COMPANY.,
ENTERPRISE.,
INSTITUTION.,
ORGANISATION or GROUP
(= attraction for highly qualified employees.)
9.. the personal c l a s s i f i c a t i o n and preference by the JOSANA MEDI:CAL PRO:JECT – Conceptors.
9.. the personal c l a s s i f i c a t i o n and preference by the JOSANA MEDI:CAL PRO:JECT – Conceptors.
Payment–Terms+Condition #III
>5<
Adlatus"
["Authorised"
Readers and Examiners.]
who will read.,
test and
examine the h i g h l y..c o n f i d e n t i a l..INTERNET–Information–DOSSIER
#.I.I.I
>Confidential Information Memorandum< during t h r e e [3]
days in
the PREMISES of authorised NOTARIES.,
depending on the ".V a l u a t i o n –
C l a s s.",
are set at single ("one–off")
amounts between 250,000
EURO [.in words : two–hundred–and–fifty–thousand Euros.]
for the ".V a l u a t i o n –
C l a s s : 1."
and a maximum of 850,000
EURO [.in words : eight–hundred–
fifty–thousand Euros.]
for the ".V a l u a t i o n – C l a s s : 5."
each plus
VAT.
The
>Access+License:Fee< payable by the "Interested Party",
also a prere-quisite for the s t r i c t l y..l i m i t e d access into the s t r i c t l y..c o n f i -
Payment–Terms+Condition #III
>6<
d e n t i a l..INTERNET–Information–DOSSIER #.I.I.I
>Confidential Informa-tion Memorandum<., i.s.,
depending on the ".V a l u a t i o n – C l a s s.",
be-tween 900,000
EURO [.in words : nine–hundred–thousand Euros.]
for the
".V a l u a t i o n – C l a s s : 1."
and a maximum of 3,060,000
EURO [.in
words : three–millions–and–sixty–thousand Euros.]
for ".V a l u a t i o n –
C l a s s : 5."
plus
VAT.
Payment–Terms+Condition
#III
>7<
The two types of fees are payable
o p t i o n a l l y
directly to the Company–
Account of the JOSANA MEDI:CAL – Licensing–, Exploratory–, Preparatory–,
Setting-Up– and Platform.:.C o m p a n y..[= Cyprus Company : "JOSANA
MEDICAL MRI STUDIOS LICENSING LIMITED."./
JÜRGEN ZIMMERMANN
] :
.JOSANA MEDICAL MRI STUDIOS LICENSING LIMITED.
BANK OF CYPRUS ( BIC : BCYPCY2N )
IBAN : CY27 0020 0195 0000 3570 3957 3127
BANK OF CYPRUS ( BIC : BCYPCY2N )
IBAN : CY27 0020 0195 0000 3570 3957 3127
.o r alternatively and o n l y on r e q u e s t.
and in each case charged with the then additionally incurred BANK–Fees of.
1,000 EURO [.in words : one–thousand Euro.] VAT–f r e e to a specially set
1,000 EURO [.in words : one–thousand Euro.] VAT–f r e e to a specially set
up "Escrow Bank Account"
with a different account–number at the BANK OF
CYPRUS (.BIC : BCYPCY2N.)
:
BANK OF CYPRUS
Larnaca Main Branch
Address : Corner of
Constantinou Palaiologou
& Tinou Street
6036 Larnaca
Republic of Cyprus., E.U.
Larnaca Main Branch
Address : Corner of
Constantinou Palaiologou
& Tinou Street
6036 Larnaca
Republic of Cyprus., E.U.
Payment–Terms+Condition #III
>8<
For the use and examination of the INTERNET–Information–DOSSIER #.I.I.I
>Confidential Information Memorandum< [".C.I.M."].,
which has n o t been
made publicly accessible and is to be treated as s t r i c t l y..c o n f i d e n -
t i a l.,
there will be apply the >Read+Checking:Fee< payable for e a c h (=
per.)."Test–Adlatus".["Authorised".Readers and Examiners.]
of an."Interest-ed Party"
for the onto t h r e e [3]
working days limited ".I n s p e c t i o n – R i g h t." (".R.e.a.d.+.R.e.v.i.e.w.+.E.x.a.m.i.n.a.t.i.o.n –.P.r i v i l e g e.")
o n -
l y and e x c l u s i v e l y in the rooms (.premises.)
of NOTARIES by express-
ly authorised NOTARY'S OFFICES in the amount of (.on average.) 550,000
EURO [.in words : five–hundred–and–fifty–thousand Euros.]
net.,
as well as
the >Access+License:Fee< of the."Interested Party",
which amounts of (.on
average.) 1,980,000
EURO [.in words : one–million–and–nine–hundred–
eighty–thousand Euros.]
n e t..
------------------------------------------------------------------------------------------
>Read+Checking:Fee<
for e a c h (=.per.) "Test–Adlatus"
["Authorised" Readers and Examiners.]
for the t h r e e–[3]–day ".I n s p e c t i o n – R i g h t."
(".R e a d + R e v i e w + E x a m i n a t i o n – P r i v i l e g e.")
in the amount of each s i n g l e ("one–off") net
".V a l u a t i o n – C l a s s : 1." --> 250,000 EURO
".V a l u a t i o n – C l a s s : 2." --> 400,000 EURO
".V a l u a t i o n – C l a s s : 3." --> 550,000 EURO
".V a l u a t i o n – C l a s s : 4." --> 700,000 EURO
".V a l u a t i o n – C l a s s : 5." --> 850,000 EURO
------------------------------------------------------------------------------------------for e a c h (=.per.) "Test–Adlatus"
["Authorised" Readers and Examiners.]
for the t h r e e–[3]–day ".I n s p e c t i o n – R i g h t."
(".R e a d + R e v i e w + E x a m i n a t i o n – P r i v i l e g e.")
in the amount of each s i n g l e ("one–off") net
".V a l u a t i o n – C l a s s : 1." --> 250,000 EURO
".V a l u a t i o n – C l a s s : 2." --> 400,000 EURO
".V a l u a t i o n – C l a s s : 3." --> 550,000 EURO
".V a l u a t i o n – C l a s s : 4." --> 700,000 EURO
".V a l u a t i o n – C l a s s : 5." --> 850,000 EURO
>Access+License:Fee<
from the "Interested Party"
in the amount of s i n g l e ("one–off") net
".V a l u a t i o n – C l a s s : 1." --> 900.000 EURO
".V a l u a t i o n – C l a s s : 2." --> 1,440,000 EURO
".V a l u a t i o n – C l a s s : 3." --> 1,980,000 EURO
".V a l u a t i o n – C l a s s : 4." --> 2,520,000 EURO
".V a l u a t i o n – C l a s s : 5." --> 3,060,000 EURO
------------------------------------------------------------------------------------------in the amount of s i n g l e ("one–off") net
".V a l u a t i o n – C l a s s : 1." --> 900.000 EURO
".V a l u a t i o n – C l a s s : 2." --> 1,440,000 EURO
".V a l u a t i o n – C l a s s : 3." --> 1,980,000 EURO
".V a l u a t i o n – C l a s s : 4." --> 2,520,000 EURO
".V a l u a t i o n – C l a s s : 5." --> 3,060,000 EURO
in the case of "Interested Parties"
from
..Countries outside the E.U. (= E.U.–Abroad )
:
w i t h (.p l u s.) 19.% VAT [= Value–added Tax.]
in the case of Intra–European "Interested Parties" from E.U.–Countries :
w i t h (.p l u s.) 19.% VAT [= Value–added Tax.]
in the case of Intra–European "Interested Parties" from E.U.–Countries :
w i t h o u t VAT–Declaration using the "Reverse–Charge–Procedure"
['.Reversal of Tax–Liability.'/.'.Reverse Charge Mechanism.']
under the
".Tax–Liability of the Recipient of the Service." (=.Invoice–Recipient.)
in accordance with the Article 196 of the EU–Directive 2006/112/EC
with Tax–Neutrality of the payer by means of Input–Tax–Deduction
------------------------------------------------------------------------------------------in accordance with the Article 196 of the EU–Directive 2006/112/EC
with Tax–Neutrality of the payer by means of Input–Tax–Deduction
.Payment–Terms+Condition #III
>9<.
The above–mentioned amounts are obligatory., in each case "u.p.s.t.r.e.a.m"
and therefore in advance in favour of the JOSANA MEDI:CAL – Licensing–,
Exploratory–,
Preparatory–,
Setting-Up– and Platform.:.C o m p a n y..[=
Cyprus Company : "JOSANA MEDICAL MRI STUDIOS LICENSING LIMITED."
/
JÜRGEN ZIMMERMANN
]
with its Registered–Office in Larnaca in the Re-public of Cyprus.,
European Union.,
to be paid JOSANA.–.Fees and JOSANA.–
Charges for the ".I n s p e c t i o n – R i g h t s." (".R e a d + R e v i e w +
E x a m i n a t i o n – P r i v i l e g e s.")
into the INTERNET–Information–
DOSSIER #.I.I.I
>.Confidential Information Memorandum.< [".C.I.M.").,
each of which is a "N E T–AMOUNT.",
what means excluding the VAT/Sales
Tax and without VAT/Sales Tax–certificate/statement.,
stating the VAT–
Identification Numbers (.VAT/Sales–Tax ID No.)
of the respective Invoice–
Issuer + Payment–Recipient a n d of the respective Invoice–Recipient +
Payment–Debtor as ".VAT–exempt..intra–Community supply or service."
from an E.U.–.Member State to the Republic of Cyprus.,
also an E.U.–.Mem-
ber State.,
or from the Republic of Cyprus.,
E.U.,
to another E.U.–.Member
State in accordance with the guidelines of the so–called ".Reversal of VAT
Liability." [".VAT Reverse Charge Procedure."]
for invoices be-tween two
[2]
companies n o t based in the same country.,
where the Invoice–Recip-ients + Payment–Debtors independently add their own country–specific
VAT (.the VAT rate is 19.%
in the Federal Republic of Germany.,
for exam-
ple.,
and also 19.%
in the Republic of Cyprus.)
to the "N E T–AMOUNT."
of
the invoice received and declare the corresponding VAT amounts to their
(.in the case of Federal Republic of Germany.,
for example :
German.)
tax
offices and deduct them again as Tax Refund Claims for input tax.,
because
in these cases the so–called "Reverse–Charge–Procedure" ["Reversal of
Tax Liability"]
is applied.,
whereby the respective ".VAT Liability of the
Service Recipient." (= Invoice–Recipient + Payment–Debtor + Payer +
Rights–User + Licensee.)
and also to the observance of the "Quick–Fixes"–
Regulations and of the Documentary–Evidence–Regulations in accordance
with the E.U.–VAT–Reform from 1
January
2020.
The respective JOSANA.–.Total–Fees./.–.Total–Charges to be paid in favour
Payment–Terms+Condition #III
>10<
The respective JOSANA.–.Total–Fees./.–.Total–Charges to be paid in favour
of the JOSANA MEDI:CAL – Licensing–, Exploratory–, Preparatory–, Setting-
Up– and Platform.:.C o m p a n y.,
the Cyprus–Company "JOSANA MEDICAL
MRI STUDIOS LICENSING LIMITED./.JÜRGEN ZIMMERMANN.".of the JOSANA
MEDI:CAL PRO:JECT – Conceptor and JOSANA MEDI:CAL M R I • S C A N –
Initiator and –.Architect and –.Licensor • J Ü R G E N..Z I M M E R M A N N •.,
as the Invoice–Issuer + Payment–Recipient + Rights–Provider + Licensor
under the application of the so–called "Reverse–Charge–Procedure" ["Re-versal of Tax Liability"]
with ".Tax Liability of the Service–Recipient." (=.In-voice–Recipient + Payment–Debtor + Payer + Rights–User + Licensee.)
are
subject to the rules of the so–called "Reverse–Charge–Procedure" ["Rever-sal of Tax Liability"].,
i.f.,
as in the case of the Federal Republic of Germany
they come from an E.U.–.Member State to the Republic of Cyprus -- also an
E.U.–.Member State -- as in the case of all invoice payments between E.U.–
Member States as well as otherwise between two [2]
companies not estab-lished in the same
country.
Payment–Terms+Condition #III
>11<
To the Fees + Charges levied in favour of the JOSANA MEDI:CAL PRO:JECT – Licensing–, Exploratory–, Preparatory–, Set-Up– and Platform.:.C.o.m.p.a.n.y
[=.Cyprus–Company : "JOSANA MEDICAL MRI STUDIOS LICENSING LIMIT-ED"./
JÜRGEN ZIMMERMANN
]
as a prerequisite and requirement for further
participation into the already initiated S e l e c t i o n –, E x c l u s i o n – and A w a r d –.P.r.o.c.e.s.s..for the selection and the accreditation of the required
'.B U I L D I N G–U P –.C O O P E R A N T S.'
and '.B U I L D I N G–U P –.P.A.R.-T I C I P A N T S.'
of the JOSANA MEDI:CAL M R I • S C A N PRO:JECT
include
the >Read+Checking:Fee< as well as the >Access+License:Fee< for access
into the s t r i c t l y..c o n f i d e n t i a l..INTERNET–Information–DOSSIER
#.I.I.I
>Confidential Information Memorandum< [".C.I.M."].,
whereby these
Fees +.Charges are non–refundable and non–off-settable.,
self–contained
and limited to the respective purpose or process and to the associated ac-
tivities and to the time frame estimated for this purpose -- also against pay-
ment -- claims or compensation for expenses and is to be paid in advance
and also is to be used.,
among other things.,
as a supplementary financing
contribution in favour of the JOSANA MEDI:CAL PRO:JECT – Conceptors for their already provided and for their future conceptual–work as well as to fi-
nance the S e l e c t i o n –, E x c l u s i o n – and A w a r d – P r o c e d u r e
carried out by the JOSANA MEDI:CAL PRO:JECT – Conceptors +.Initiators +.Architects +.Licensors and for the JOSANA MEDI:CAL – "
S t a r t i n g –
F i n a n c i n g "
and for the ".a c c o m p a n y i n g..L i q u i d i t y – F i -
n a n c i n g."
of the planned "JOSANA MEDI:CAL.WORLD:GROUP.",
but does
not represent any remuneration for the contents or information of the JO-
SANA MEDI:CAL PRO:JECT – Conceptors + Initiators + Architects + Licen-sors • Z I M M E R M A N N..& R E H N I S C H • regarding their joint JOSANA
MEDI:CAL LONG:TERM..DISEASE.:.PREVENTION M R I • S C A N PRO:JECT or
for their respective Knowledge or
Know–How.
Payment–Terms+Condition #III >12<
In the event of the w a i v e r and/or in the event of the m i s s i n g call–off
the INTERNET–Information–DOSSIER #.I.I
>F.I.R.S.T.–.I.N.F.O.R.M.A.T.I.O.N< which provides the basis and further important details about the secret JO-SANA MEDI:CAL M R I • S C A N PRO:JECT.,
the respective (.potentially.)
"In-terested Party"
shall be subject to the..i r r e v e r s i b l e ".E..& H – C U T -
T I N G.".
The ".E..& H – C U T T I N G."..is the w o r l d w i d e valid E X C L U S I O N –
The ".E..& H – C U T T I N G."..is the w o r l d w i d e valid E X C L U S I O N –
Decision of the JOSANA MEDI:CAL PRO:JECT – Conceptors + Initiators +
Architects + Licensors • Z I M M E R M A N N..& R E H N I S C H • in relation
to their joint JOSANA MEDI:CAL M R I • S C A N PRO:JECT and on a possible
function of the."Interested Party"
as '.B.U.I.L.D.I.N.G–U.P –.C.O.O.P.E.R.A.N.T
'
(=.Cooperation–Partner.)
and '.B.U.I.L.D.I.N.G–U.P –.P.A.R.T.I.C.I.P.A.N.T.'
(=
Participation–Partner.)
of the worldwide JOSANA MEDI:CAL M R I • S C A N PRO:JECT.
N o t e : With regard to the ".E..& H – C U T T I N G.", the JOSANA MEDI:CAL
N o t e : With regard to the ".E..& H – C U T T I N G.", the JOSANA MEDI:CAL
..............PRO:JECT.–.Conceptors make s t r i c t and m e r c i l e s s decisions !
This i r r e v e r s i b l e and w.o.r.l.d.w.i.d.e..E X C L U S I O N of a FIRM.,.COM-PANY., ENTERPRISE., INSTITUTION., ORGANISATION or GROUP applies N.O.T only to the respective FIRM or COMPANY or ENTERPRISE or INSTITUTION or
Payment–Terms+Condition #III >13<
This i r r e v e r s i b l e and w.o.r.l.d.w.i.d.e..E X C L U S I O N of a FIRM.,.COM-PANY., ENTERPRISE., INSTITUTION., ORGANISATION or GROUP applies N.O.T only to the respective FIRM or COMPANY or ENTERPRISE or INSTITUTION or
ORGANISATION or GROUP.,
but in particular also to their -- including foreign
-- Branches.,
Parent–Companies or Subsidiaries and a l s o to a l l other Com-panies.,
Institutions as well as Holdings.,
otherwise involved into the respec-tive Corporate–Network of any.(.potentially.)
interested FIRM or COMPANY.or
ENTERPRISE or INSTITUTION or ORGANISATION or GROUP.,
and a l s o for
a l l..other Business–Relationships.,
Customer–Relationships or Partnership–
Relationships.,
including those from the Group of Companies or Corporate–
Group of the
(.potentially.)
interested FIRM.,.COMPANY,
ENTERPRISE.,.INSTI-TUTION.,
ORGANISATION or GROUP ["Interested Party"].
P D F–Retrieval :
Payment–Conditions for DOSSIER #III
